These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19468204)

  • 41. BCL2 gene aberration as an IPI-independent marker for poor outcome in non-germinal-centre diffuse large B cell lymphoma.
    Obermann EC; Csato M; Dirnhofer S; Tzankov A
    J Clin Pathol; 2009 Oct; 62(10):903-7. PubMed ID: 19783718
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of immunohistochemistry in the era of genetic testing in MYC-positive aggressive B-cell lymphomas: a study of 209 cases.
    Agarwal R; Lade S; Liew D; Rogers TM; Byrne D; Feleppa F; Juneja S; Westerman DA
    J Clin Pathol; 2016 Mar; 69(3):266-70. PubMed ID: 26307073
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Follicular lymphoma grade 3B.
    Salaverria I; Siebert R
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):111-9. PubMed ID: 21658612
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The diagnostic value of kappa/lambda ratios determined by flow cytometric analysis of biopsy specimens in B-cell lymphoma.
    Chizuka A; Kanda Y; Nannya Y; Oshima K; Kaneko M; Yamamoto R; Suguro M; Hamaki T; Matsuyama T; Takezako N; Miwa A; Togawa A
    Clin Lab Haematol; 2002 Feb; 24(1):33-6. PubMed ID: 11843896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations.
    Visco C; Wang J; Tisi MC; Deng L; D'Amore ESG; Tzankov A; Montes-Moreno S; Dybkær K; Bhagat G; Hsi ED; van Krieken JH; Ponzoni M; Ferreri AJM; Møller MB; Piris MA; Medeiros LJ; Xu-Monette ZY; Young KH
    Br J Cancer; 2017 Nov; 117(11):1685-1688. PubMed ID: 28949959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-immunoglobulin/BCL6 gene fusion in diffuse large B-cell lymphoma: prognostic implications.
    Ueda C; Akasaka T; Ohno H
    Leuk Lymphoma; 2002 Jul; 43(7):1375-81. PubMed ID: 12389616
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD56-positive diffuse large B-cell lymphoma: possible association with extranodal involvement and bcl-6 expression.
    Gomyo H; Kajimoto K; Miyata Y; Maeda A; Mizuno I; Yamamoto K; Obayashi C; Hanioka K; Murayama T
    Hematology; 2010 Jun; 15(3):157-61. PubMed ID: 20557674
    [TBL] [Abstract][Full Text] [Related]  

  • 48. De novo nodal diffuse large B-cell lymphoma: identification of biologic prognostic factors.
    Abd El-Hameed A
    J Egypt Natl Canc Inst; 2005 Mar; 17(1):20-8. PubMed ID: 16353079
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical significance of bcl-2-MBR gene rearrangement and protein expression in diffuse large-cell non-Hodgkin's lymphoma: an analysis of 83 cases.
    Tang SC; Visser L; Hepperle B; Hanson J; Poppema S
    J Clin Oncol; 1994 Jan; 12(1):149-54. PubMed ID: 8270971
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surface immunoglobulin light chain expression in pre-B cell leukemias.
    Koziner B; Stavnezer J; Al-Katib A; Gebhard D; Mittelman A; Andreeff M; Clarkson BD
    Ann N Y Acad Sci; 1986; 468():211-26. PubMed ID: 2425686
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The utility of multiparametric seven-color flow cytometry in the detection of double hit lymphoma in ascitic fluid samples.
    Cordoba R; Alvarez B; Masso P; Gonzalez FA; Conejo L; Velasco D; Alonso JM; Villarrubia J; Cava F; Llamas P
    Cytometry B Clin Cytom; 2016 Nov; 90(6):543-545. PubMed ID: 25612555
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries.
    Xu-Monette ZY; Tu M; Jabbar KJ; Cao X; Tzankov A; Visco C; Nagarajan L; Cai Q; Montes-Moreno S; An Y; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Zhao X; Møller MB; Farnen JP; Winter JN; Piris MA; Miranda RN; Medeiros LJ; Young KH
    Oncotarget; 2015 Mar; 6(8):5615-33. PubMed ID: 25760242
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hematogones with light chain restriction: A potential diagnostic pitfall when using flow cytometry analysis to assess bone marrow specimens.
    El Hussein S; Wang W; Wang SA; Fang H; Garces S; Tashakori M; Lyapichev KA; Qiu L; Wang X; Loghavi S; Medeiros LJ; Challagundla P; Jorgensen JL
    Leuk Res; 2021 Dec; 111():106704. PubMed ID: 34735934
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PD1 and PDL1 expression in primary central nervous system diffuse large B-cell lymphoma are frequent and expression of PD1 predicts poor survival.
    Four M; Cacheux V; Tempier A; Platero D; Fabbro M; Marin G; Leventoux N; Rigau V; Costes-Martineau V; Szablewski V
    Hematol Oncol; 2017 Dec; 35(4):487-496. PubMed ID: 27966264
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparative study of molecular characteristics of diffuse large B-cell lymphoma from patients with and without human immunodeficiency virus infection.
    Chao C; Silverberg MJ; Xu L; Chen LH; Castor B; Martínez-Maza O; Abrams DI; Zha HD; Haque R; Said J
    Clin Cancer Res; 2015 Mar; 21(6):1429-37. PubMed ID: 25589617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Flow cytometry aneuploidy and cell cycle indexing as a possible tool for differentiating between CD10
    Azoulay D; Cohen HI; Dementiev E; Eshel E; Akria L; Shaoul E; Horowitz N
    Cytometry B Clin Cytom; 2020 Sep; 98(5):449-453. PubMed ID: 31816181
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel bioinformatic classification system for genetic signatures identification in diffuse large B-cell lymphoma.
    Zhang W; Yang L; Guan YQ; Shen KF; Zhang ML; Cai HD; Wang JC; Wang Y; Huang L; Cao Y; Wang N; Tan XH; Young KH; Xiao M; Zhou JF
    BMC Cancer; 2020 Jul; 20(1):714. PubMed ID: 32736575
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors determining whether diffuse large B-cell lymphoma samples are detected by flow cytometry.
    Peng D; Kodituwakku A; Le S; Smith SABC; Qiu MR; Earls P; Field AS; Parker AJC; Law M; Milliken ST; Sewell WA
    Int J Lab Hematol; 2023 Dec; 45(6):927-934. PubMed ID: 37632200
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Flow cytometric detection and quantification of CD56 (neural cell adhesion molecule, NCAM) expression in diffuse large B cell lymphomas and review of the literature.
    Stacchini A; Barreca A; Demurtas A; Aliberti S; di Celle PF; Novero D
    Histopathology; 2012 Feb; 60(3):452-9. PubMed ID: 22276608
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prominent Dutcher body formation in a case of follicular lymphoma with BCL6 gene rearrangement and intact BCL2 gene.
    Kulbacki E; Rehder C; Wang E
    Am J Hematol; 2010 Mar; 85(3):218-9. PubMed ID: 20069653
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.